1. Academic Validation
  2. Spinocerebellar ataxia: an update

Spinocerebellar ataxia: an update

  • J Neurol. 2019 Feb;266(2):533-544. doi: 10.1007/s00415-018-9076-4.
Roisin Sullivan 1 Wai Yan Yau 2 Emer O'Connor 2 Henry Houlden 2
Affiliations

Affiliations

  • 1 Department of Neuromuscular Diseases, UCL Queen's Square Institute of Neurology, Queen's Square House, Queen's Square, London, WC1N 3BG, UK. [email protected].
  • 2 Department of Neuromuscular Diseases, UCL Queen's Square Institute of Neurology, Queen's Square House, Queen's Square, London, WC1N 3BG, UK.
Abstract

Spinocerebellar ataxia (SCA) is a heterogeneous group of neurodegenerative ataxic disorders with autosomal dominant inheritance. We aim to provide an update on the recent clinical and scientific progresses in SCA where numerous novel genes have been identified with next-generation sequencing techniques. The main disease mechanisms of these SCAs include toxic RNA gain-of-function, mitochondrial dysfunction, channelopathies, Autophagy and transcription dysregulation. Recent studies have also demonstrated the importance of DNA repair pathways in modifying SCA with CAG expansions. In addition, we summarise the latest technological advances in detecting known and novel repeat expansion in SCA. Finally, we discuss the roles of Antisense Oligonucleotides and RNA-based therapy as potential treatments.

Keywords

Molecular diagnosis; Next-generation sequencing; Spinocerebellar ataxia.

Figures